In conclusion, the results show that Bcl9 and more prominently Bcl9L contribute to the initiation and maintenance of TGFβ-induced EMT and cell migration of cultured mammary tumor cells in vitro, but that they are not exclusive determinants of these TGFβ-induced processes. Here, BCL9 is linked to breast cancer.